XML 64 R50.htm IDEA: XBRL DOCUMENT
v3.10.0.1

EMPLOYEE BENEFIT PLANS (Summary of Stock Options and Stock Appreciation Rights Outstanding and Exercisable) (Details) shares in Thousands | 6 Months Ended
--- | ---
Jun. 30, 2018 $ / shares shares
Cash Stock Appreciation Rights |
Stock-based compensation plans disclosures |
Equity instruments other than options outstanding, number of shares (in shares) | shares | 61
Equity instruments other than options outstanding, weighted- average exercise price (in dollars per share) | $ 36.73
Equity instruments other than options outstanding, weighted- average remaining contractual term | 8 months 12 days
Equity instruments other than options exercisable, number of shares (in shares) | shares | 38
Equity instruments other than options exercisable, weighted- average exercise price (in dollars per share) | $ 36.73
Stock options |
Stock-based compensation plans disclosures |
Stock options outstanding, number of shares (in shares) | shares | 275
Stock options outstanding, weighted- average exercise price (in dollars per share) | $ 90.16
Stock options outstanding, weighted- average remaining contractual term | 2 years 6 months
Stock options exercisable, number of shares (in shares) | shares | 275
Stock options exercisable, weighted- average exercise price (in dollars per share) | $ 90.16
Stock appreciation rights |
Stock-based compensation plans disclosures |
Equity instruments other than options outstanding, number of shares (in shares) | shares | 1,667
Equity instruments other than options outstanding, weighted- average exercise price (in dollars per share) | $ 44.40
Equity instruments other than options outstanding, weighted- average remaining contractual term | 1 year 8 months 12 days
Equity instruments other than options exercisable, number of shares (in shares) | shares | 1,104
Equity instruments other than options exercisable, weighted- average exercise price (in dollars per share) | $ 47.94
$29.78 - $47.99 | Cash Stock Appreciation Rights |
Stock-based compensation plans disclosures |
Equity instruments other than options outstanding, lower range (in dollars per share) | 29.78
Equity instruments other than options outstanding, upper range (in dollars per share) | $ 47.99
Equity instruments other than options outstanding, number of shares (in shares) | shares | 61
Equity instruments other than options outstanding, weighted- average exercise price (in dollars per share) | $ 36.73
Equity instruments other than options outstanding, weighted- average remaining contractual term | 8 months 12 days
Equity instruments other than options exercisable, number of shares (in shares) | shares | 38
Equity instruments other than options exercisable, weighted- average exercise price (in dollars per share) | $ 36.73
$29.78 - $47.99 | Stock options |
Stock-based compensation plans disclosures |
Stock options outstanding, lower range (in dollars per share) | 29.78
Stock options outstanding, upper range (in dollars per share) | $ 47.99
Stock options outstanding, number of shares (in shares) | shares | 43
Stock options outstanding, weighted- average exercise price (in dollars per share) | $ 38.40
Stock options outstanding, weighted- average remaining contractual term | 1 year 6 months
Stock options exercisable, number of shares (in shares) | shares | 43
Stock options exercisable, weighted- average exercise price (in dollars per share) | $ 38.40
$29.78 - $47.99 | Stock appreciation rights |
Stock-based compensation plans disclosures |
Equity instruments other than options outstanding, lower range (in dollars per share) | 29.78
Equity instruments other than options outstanding, upper range (in dollars per share) | $ 47.99
Equity instruments other than options outstanding, number of shares (in shares) | shares | 1,423
Equity instruments other than options outstanding, weighted- average exercise price (in dollars per share) | $ 37.93
Equity instruments other than options outstanding, weighted- average remaining contractual term | 1 year 3 months 19 days
Equity instruments other than options exercisable, number of shares (in shares) | shares | 895
Equity instruments other than options exercisable, weighted- average exercise price (in dollars per share) | $ 38.00
$13.65 - $29.49 | Stock options |
Stock-based compensation plans disclosures |
Stock options outstanding, lower range (in dollars per share) | 13.65
Stock options outstanding, upper range (in dollars per share) | $ 29.49
Stock options outstanding, number of shares (in shares) | shares | 22
Stock options outstanding, weighted- average exercise price (in dollars per share) | $ 14.41
Stock options outstanding, weighted- average remaining contractual term | 7 months 6 days
Stock options exercisable, number of shares (in shares) | shares | 22
Stock options exercisable, weighted- average exercise price (in dollars per share) | $ 14.41
$13.65 - $29.49 | Stock appreciation rights |
Stock-based compensation plans disclosures |
Equity instruments other than options outstanding, lower range (in dollars per share) | 13.65
Equity instruments other than options outstanding, upper range (in dollars per share) | $ 29.49
Equity instruments other than options outstanding, number of shares (in shares) | shares | 48
Equity instruments other than options outstanding, weighted- average exercise price (in dollars per share) | $ 29.49
Equity instruments other than options outstanding, weighted- average remaining contractual term | 6 years 1 month 6 days
Equity instruments other than options exercisable, number of shares (in shares) | shares | 16
Equity instruments other than options exercisable, weighted- average exercise price (in dollars per share) | $ 29.49
$55.04 - $83.83 | Stock options |
Stock-based compensation plans disclosures |
Stock options outstanding, lower range (in dollars per share) | 55.04
Stock options outstanding, upper range (in dollars per share) | $ 83.83
Stock options outstanding, number of shares (in shares) | shares | 87
Stock options outstanding, weighted- average exercise price (in dollars per share) | $ 81.35
Stock options outstanding, weighted- average remaining contractual term | 2 years 4 months 24 days
Stock options exercisable, number of shares (in shares) | shares | 87
Stock options exercisable, weighted- average exercise price (in dollars per share) | $ 81.35
$55.04 - $83.83 | Stock appreciation rights |
Stock-based compensation plans disclosures |
Equity instruments other than options outstanding, lower range (in dollars per share) | 55.04
Equity instruments other than options outstanding, upper range (in dollars per share) | $ 83.83
Equity instruments other than options outstanding, number of shares (in shares) | shares | 110
Equity instruments other than options outstanding, weighted- average exercise price (in dollars per share) | $ 79.03
Equity instruments other than options outstanding, weighted- average remaining contractual term | 4 years
Equity instruments other than options exercisable, number of shares (in shares) | shares | 107
Equity instruments other than options exercisable, weighted- average exercise price (in dollars per share) | $ 79.55
$95.91 - $131.46 | Stock options |
Stock-based compensation plans disclosures |
Stock options outstanding, lower range (in dollars per share) | 95.91
Stock options outstanding, upper range (in dollars per share) | $ 131.46
Stock options outstanding, number of shares (in shares) | shares | 123
Stock options outstanding, weighted- average exercise price (in dollars per share) | $ 127.98
Stock options outstanding, weighted- average remaining contractual term | 3 years 2 months 12 days
Stock options exercisable, number of shares (in shares) | shares | 123
Stock options exercisable, weighted- average exercise price (in dollars per share) | $ 127.98
$95.91 - $131.46 | Stock appreciation rights |
Stock-based compensation plans disclosures |
Equity instruments other than options outstanding, lower range (in dollars per share) | 95.91
Equity instruments other than options outstanding, upper range (in dollars per share) | $ 131.46
Equity instruments other than options outstanding, number of shares (in shares) | shares | 86
Equity instruments other than options outstanding, weighted- average exercise price (in dollars per share) | $ 115.60
Equity instruments other than options outstanding, weighted- average remaining contractual term | 2 years 7 months 6 days
Equity instruments other than options exercisable, number of shares (in shares) | shares | 86
Equity instruments other than options exercisable, weighted- average exercise price (in dollars per share) | $ 115.60

X
- Definition The number of shares into which equity instruments other than options outstanding as of the balance sheet date can be currently converted under the stock-based compensation plan. + References No definition available. + Details
Name: | fosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber
Namespace Prefix: | fosl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on equity instruments, other than options, outstanding and currently exercisable under the stock-based compensation plan. + References No definition available. + Details
Name: | fosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice
Namespace Prefix: | fosl_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock compensation plan, other than options. + References No definition available. + Details
Name: | fosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
Namespace Prefix: | fosl_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock appreciation rights awards on all stock appreciation rights plans and other required information pertaining to awards in the customized range. + References No definition available. + Details
Name: | fosl_ShareBasedCompensationSharesAuthorizedUnderEquityPlansOtherThanOptionsExercisePriceRangeLowerRangeLimit
Namespace Prefix: | fosl_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock appreciation rights awards on all stock appreciation rights plans and other required information pertaining to awards in the customized range. + References No definition available. + Details
Name: | fosl_ShareBasedCompensationSharesAuthorizedUnderEquityPlansOtherThanOptionsExercisePriceRangeUpperRangeLimit
Namespace Prefix: | fosl_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of options outstanding, including both vested and non-vested options. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=fosl_CashStockAppreciationRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=fosl_EmployeeAndNonemployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | fosl_PriceAxis=fosl_RangeTwoOfExercisePricesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | fosl_PriceAxis=fosl_RangeOneOfExercisePricesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | fosl_PriceAxis=fosl_RangeThreeOfExercisePricesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | fosl_PriceAxis=fosl_RangeFourOfExercisePricesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |